LPL Financial
PCRX icon

LPL Financial’s Pacira BioSciences PCRX Stock Holding History

LPL Financial’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724K Sell
28,524
-52,427
-65% -$1.24M ﹤0.01% 4709
2026
Q1 		$1.83M Buy
80,951
+7,511
+10% +$167K ﹤0.01% 3603
2025
Q4 		$1.9M Buy
73,440
+47,224
+180% +$1.12M ﹤0.01% 3464
2025
Q3 		$676K Sell
26,216
-40,977
-61% -$1.01M ﹤0.01% 4377
2025
Q2 		$1.61M Buy
67,193
+42,288
+170% +$1.07M ﹤0.01% 3332
2025
Q1 		$619K Buy
24,905
+11,584
+87% +$277K ﹤0.01% 3971
2024
Q4 		$251K Buy
+13,321
New +$234K ﹤0.01% 4666
2024
Q3 		– Sell
-7,464
Closed -$214K – 5265
2024
Q2 		$214K Buy
+7,464
New +$212K ﹤0.01% 4519
2024
Q1 		– Sell
-6,448
Closed -$218K – 4997
2023
Q4 		$218K Buy
+6,448
New +$189K ﹤0.01% 4329
2023
Q1 		– Sell
-6,113
Closed -$236K – 4559
2022
Q4 		$236K Sell
6,113
-689
-10% -$33.5K ﹤0.01% 3853
2022
Q3 		$362K Sell
6,802
-689
-9% -$38.3K ﹤0.01% 3421
2022
Q2 		$437K Buy
7,491
+77
+1% +$5.04K ﹤0.01% 3321
2022
Q1 		$566K Buy
7,414
+161
+2% +$10.7K ﹤0.01% 3095
2021
Q4 		$436K Buy
7,253
+1,033
+17% +$57K ﹤0.01% 3397
2021
Q3 		$348K Buy
6,220
+649
+12% +$37.4K ﹤0.01% 3530
2021
Q2 		$338K Buy
5,571
+2,101
+61% +$133K ﹤0.01% 3494
2021
Q1 		$243K Buy
+3,470
New +$248K ﹤0.01% 3621
2016
Q1 		– Sell
-2,968
Closed -$221K – 3180
2015
Q4 		$221K Buy
+2,968
New +$168K ﹤0.01% 2751
2014
Q3 		– Sell
-10,393
Closed -$955K – 2765
2014
Q2 		$955K Buy
+10,393
New +$791K 0.01% 1359

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's PCRX Position: Q2 2026 in Review

LPL Financial reduced its Pacira BioSciences (PCRX) stake by 65% in Q2 2026, selling an estimated $1.24M and leaving 28,524 shares worth $724K. The position accounts for ﹤0.01% of the portfolio, ranked #4709.

LPL Financial first reported a position in PCRX in Q2 2014 and has held it in 19 quarters since. The position peaked at $1.9M in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • LPL Financial held 28,524 shares of Pacira BioSciences worth $724K as of Q2 2026.
  • LPL Financial sold 52,427 Pacira BioSciences shares in Q2 2026, an estimated $1.24M.
  • Pacira BioSciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4709 holding.
  • LPL Financial first reported a position in Pacira BioSciences in Q2 2014 and has held it in 19 quarters since.
  • LPL Financial's Pacira BioSciences position peaked at $1.9M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.